Showing posts with label Hollywood. Show all posts
Showing posts with label Hollywood. Show all posts

Tuesday, April 20, 2010

the big story

Hooray for the Next Bubble



Box office derivatives - betting box office results et al - is likely to bring the American entertainment industry to the brink in the near future


Hollywood usually embraces all that's trendy and hip. But moguls don't mind seeming like fuddy-duddies as they mobilize their heavy PR artillery against a new business proposal: futures trading based on a movie's box office performance.

Tinseltown got a jolt on Friday when the U.S. Commodity Futures Trading Commission authorized a company called Media Derivatives to create an exchange for movie futures. It would sell contracts that anticipate how much revenue a flick will generate from domestic ticket sales. Buyers would make or lose money based on the actual results.

Trade groups led by the Motion Picture Association of America say that's a form of gambling that invites chicanery. For example, a movie exhibitor could bet against a movie and then effectively throw the game by cutting its ad spending. Or someone could try to manipulate the market by spreading rumors that, say, the star of a big film is in rehab.

What's more, the pay offs for the contracts are based on nothing more than unofficial studio estimates about box office sales. There's no law to prevent a studio from estimating too high, or low.

"After the fiscal meltdown from which our country is still struggling to emerge, we have seen the danger of abusive financial practices," the MPAA and groups representing directors and theater owners said in a statement. "Now is the time to strengthen and stabilize our financial system, not the time to open the floodgates on an untested, and unwanted plan that could cause serious harm to an important American industry and its workers."

Read more...

Monday, April 19, 2010

CoOlDiGgY tech & media

Scientists edge closer to printing human tissue



A new technology early in clinical trials could make it possible for doctors to use specialized 3D printers to fabricate new human tissue based on a patient's own cells.

Known as commercial bioprinting, the technology from San Diego start-up Organovo starts with cells from adipose tissue--essentially body fat--or bone marrow and is intended to use those cells as the basis for making new tissue.

As of right now, the benefit for humans is still years away, perhaps as many as four, said Organovo CEO Keith Murphy. And when and if the company's technology gets certified and hits the market, it will probably have limited application: most likely, the technology could be used at first mainly for crafting very small areas of tissue or new blood vessels.

But even those limited applications could mean, for example, that doctors may eventually have the ability to intervene in cases where, for example, a patient has a blocked or damaged blood vessel, and potentially prevent what might otherwise result in a forced amputation. Similarly, someone with damaged nerves could have a gap in a nerve bridged using regenerated cells printed by Organovo's machine.

Read more...

*JooJoo Tablet Is a Real Piece of DooDoo

*Group challenging enhanced surveillance law faces uphill climb

*28 Time-Saving Tricks for Google, Facebook, and More

*Sugar-to-diesel maker Amyris files for IPO


*The Entertainment Industry's Dystopia of the Future

*Fox too liberal for you? Kelsey Grammer backs upstart right-wing TV network, RightNetwork

*UK upholds ban on "misleading" Israel tourism ad

*Rare earth element miner seeks to expand in US

Followers